US-listed Prenetics acquires Asia-based genomics company ACT Genomics
Prenetics Global Limited, a United States-listed genomic and diagnostic testing firm, has announced that it is acquiring a majority stake in ACT Genomics Holdings Company Limited, an Asia based genomics company specializing in precision oncology.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed